Author: Wolters Kluwer Health
Publisher: Wolters Kluwer Health
ISBN: 9781574393064
Category : Chemotherapy
Languages : en
Pages : 0
Get Book Here
Book Description
Drug Facts and Comparisons contains up-to-date, comprehensive information on over 22,000 Rx and 6,000 OTC items grouped by therapeutic category for ease of comparison. The book answers questions about actions, indications and contraindications; warnings and precautions; interactions between drugs; adverse reactions; administration, dosage, and overdosage; and patient information. Comparisons provided include drug to drug; different dosage forms; name brands are compared to name brands and to generics. Facts and Comparisons are also given on Centers for Disease Control biologicals and antiparasitic drugs; IV solutions; therapeutic and diagnostic ophthalmic preparations; diagnostic aids and radiographic contrast media and products; NCI investigational chemotherapeutic drugs; and combination cancer chemotherapy regimens. This hardbound edition includes the Drug Identifier 2010 CD-ROM, the premier tool for correct drug identification. Ensure accuracy by searching through more than 5,000 color images in seconds. Search by drug name, imprint, NDC code, color, shape, manufacturer, coating, scoring, clarity, and flavor.
Author:
Publisher:
ISBN:
Category : Chemotherapy
Languages : en
Pages : 3782
Get Book Here
Book Description
Comprehensive drug information reference source intended for health professionals. Arranged by therapeutic drug classes. Each entry (monograph) gives detailed information covering such topics as actions, adverse reactions, and overdosage. General index.
Author: Sean C. Sweetman
Publisher:
ISBN: 9780853697046
Category : Medical
Languages : en
Pages : 3335
Get Book Here
Book Description
This is thirty-fifth edition of Martindale, which provides reliable, and evaluated information on drugs and medicines used throughout the world. It contains encyclopaedic facts about drugs and medicines, with: 5,500 drug monographs; 128,000 preparations; 40,700 reference citations; 10,900 manufacturers. There are synopses of disease treatments which enables identification of medicines, the local equivalent and the manufacturer. It also Includes herbals, diagnostic agents, radiopharmaceuticals, pharmaceutical excipients, toxins, and poisons as well as drugs and medicines. Based on published information and extensively referenced
Author:
Publisher:
ISBN: 9781574393194
Category : Chemicals
Languages : en
Pages : 0
Get Book Here
Book Description
Drug Facts and Comparisons contains up-to-date, comprehensive information on over 22,000 Rx and 6,000 OTC items grouped by therapeutic category for ease of comparison. The book answers questions about actions, indications and contraindications; warnings and precautions; interactions between drugs; adverse reactions; administration, dosage, and overdosage; and patient information. Comparisons provided include drug to drug; different dosage forms; name brands are compared to name brands and to generics. Facts and Comparisons are also given on Centers for Disease Control biologicals and antiparasitic drugs; IV solutions; therapeutic and diagnostic ophthalmic preparations; diagnostic aids and radiographic contrast media and products; NCI investigational chemotherapeutic drugs; and combination cancer chemotherapy regimens. This hardbound edition includes the Drug Identifier 2011 CD-ROM, the premier tool for correct drug identification. Ensure accuracy by searching through more than 5,000 color images in seconds. Search by drug name, imprint, NDC code, color, shape, manufacturer, coating, scoring, clarity, and flavor.
Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
ISBN: 0309468086
Category : Medical
Languages : en
Pages : 235
Get Book Here
Book Description
Thanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were long deemed untreatable. At the same time, however, the United States is facing the vexing challenge of a seemingly uncontrolled rise in the cost of health care. Total medical expenditures are rapidly approaching 20 percent of the gross domestic product and are crowding out other priorities of national importance. The use of increasingly expensive prescription drugs is a significant part of this problem, making the cost of biopharmaceuticals a serious national concern with broad political implications. Especially with the highly visible and very large price increases for prescription drugs that have occurred in recent years, finding a way to make prescription medicinesâ€"and health care at largeâ€"more affordable for everyone has become a socioeconomic imperative. Affordability is a complex function of factors, including not just the prices of the drugs themselves, but also the details of an individual's insurance coverage and the number of medical conditions that an individual or family confronts. Therefore, any solution to the affordability issue will require considering all of these factors together. The current high and increasing costs of prescription drugsâ€"coupled with the broader trends in overall health care costsâ€"is unsustainable to society as a whole. Making Medicines Affordable examines patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design. This report explores structural and policy factors influencing drug pricing, drug access programs, the emerging role of comparative effectiveness assessments in payment policies, changing finances of medical practice with regard to drug costs and reimbursement, and measures to prevent drug shortages and foster continued innovation in drug development. It makes recommendations for policy actions that could address drug price trends, improve patient access to affordable and effective treatments, and encourage innovations that address significant needs in health care.
Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
ISBN: 0309459575
Category : Medical
Languages : en
Pages : 483
Get Book Here
Book Description
Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.
Author: Ara DerMarderosian
Publisher:
ISBN: 9781574392258
Category : Materia medica
Languages : en
Pages : 0
Get Book Here
Book Description
The Review of Natural Products is the foremost source of current natural product information for health care professionals. More than 300 in-depth monographs are included, based on scientific research, not just anecdotal information. The Review of Natural Products provides detailed information about natural products, including their botany, history, chemistry, pharmacology, medicinal uses, toxicology, and patient information. It also includes significantly documented drug interactions.
Author: Norman F. Billups
Publisher:
ISBN: 9780932686312
Category : Drugs
Languages : en
Pages : 900
Get Book Here
Book Description
Author: Charles F. Lacy
Publisher:
ISBN:
Category : Medical
Languages : en
Pages : 1836
Get Book Here
Book Description
Author: Institute of Medicine
Publisher: National Academies Press
ISBN: 0309090776
Category : Medical
Languages : en
Pages : 551
Get Book Here
Book Description
Americans should be able to count on receiving health care that is safe. To achieve this, a new health care delivery system is needed â€" a system that both prevents errors from occurring, and learns from them when they do occur. The development of such a system requires a commitment by all stakeholders to a culture of safety and to the development of improved information systems for the delivery of health care. This national health information infrastructure is needed to provide immediate access to complete patient information and decision-support tools for clinicians and their patients. In addition, this infrastructure must capture patient safety information as a by-product of care and use this information to design even safer delivery systems. Health data standards are both a critical and time-sensitive building block of the national health information infrastructure. Building on the Institute of Medicine reports To Err Is Human and Crossing the Quality Chasm, Patient Safety puts forward a road map for the development and adoption of key health care data standards to support both information exchange and the reporting and analysis of patient safety data.
